Monthly Archives: July 2023
News
Acepodia enters strategic clinical collaboration with Pfizer to accelerate development of antibody-cell conjugation-based cell...
Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (γδ2) T cell platforms,...
Innovent receives Fast Track Designation from the U.S. FDA for IBI363 as monotherapy for...
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Innovent Biologics' PD-1/IL-2α-bias Bispecific Antibody Fusion Protein (R&D code: IBI363), for...
Skyline Therapeutics’ novel gene therapy SKG1108 receives FDA Orphan Drug Designation for Retinitis Pigmentosa
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Skyline Therapeutics' SKG1108, a novel one-time intravitreally delivered gene therapy...
